JClinPath_BMJ

OPEN ACCESS! 🔬 Claudin 18.2 expression in Gallbladder cancer 🩺 Favourable prognosis 🕵️‍♀️ Improved immune microenvironment 💊 Targeted treatment options! Learn more - bit.ly/4f9xCGJ

Evaluating HER2-low breast cancer (OPEN ACCESS) 🧬 It's low—even among experts. Subspecialised breast pathologists showed poor agreement in assessing HER2-low breast cancer. 🧪 A modified algorithm (based on Ki-67 scoring) was tested to improve consistency, but showed only a…

It gives us immense pleasure to announce the first ACP–JCP Early Career Prize for Best Original Paper. 🏆 Congratulations to the authors of this outstanding work on AI-driven PD-L1 and TILs scoring in NSCLC! jcp.bmj.com/content/78/7/4… @JClinPath_BMJ @ACP_Pathologist

🆕 Calcified chondroid mesenchymal neoplasm 🔬 Newly defined soft tissue tumor with diagnostic challenges ! 🧬 Benign, Molecularly unique 🤓 Distinct histology with close morphologic mimics ⚠️ Pitfall! Radiology can look aggressive Learn some diagnostic tips right here -…

❓ What are the patterns of HER2 expression in lung adenocarcinomas ? ❓ Do HER2 positive tumours show ERBB2 mutations ? ❓ Is HER2 testing in cytology samples good enough ? Watch this video to find out more and read all about it right here bit.ly/3S0Tcml

🆕 Calcified chondroid mesenchymal neoplasm 🔬 Newly defined soft tissue tumor with diagnostic challenges ! 🧬 Benign, Molecularly unique 🤓 Distinct histology with close morphologic mimics ⚠️ Pitfall! Radiology can look aggressive Learn some diagnostic tips right here -…

📢 The first ACP–JCP Early Career Prize for Best Original Paper has just been announced!! 🏆 And here's a sneak peak! Read more - bit.ly/3IxIqTb @ACP_Pathologist @JClinPath_BMJ

🔬 HER2-low is common in gastro-oesophageal adenocarcinoma—seen in 28.3% of cases (1+ or 2+ w/o amplification). bit.ly/49zNGiw bit.ly/4m02mw5

Tumour-infiltrating lymphocyte subsets and their individual prognostic impact in oral squamous cell carcinoma"@aanchalkakkar @mun_mm bit.ly/4kHRnq5

Relationship between somatostatin receptor 2 (SSTR2) and epidermal growth factor receptor (EGFR) in nasopharyngeal carcinoma (NPC). bit.ly/4kN4NkA

It gives us immense pleasure to announce the first ACP–JCP Early Career Prize for Best Original Paper. 🏆 Congratulations to the authors of this outstanding work on AI-driven PD-L1 and TILs scoring in NSCLC! jcp.bmj.com/content/78/7/4… @JClinPath_BMJ @ACP_Pathologist

Ever heard of 'Shaken biopsies' ? 🤔 Read about this novel way to obtain material for genomics ! Open access too 🎉 bit.ly/3S6zw0i

💡 Liquid biopsies to detect EGFR mutations in NSCLC - Does it work ? Find out! bit.ly/3F6C0Ji

💡 Liquid biopsies to detect EGFR mutations in NSCLC - Does it work ? Find out! bit.ly/3F6C0Ji

We need to start considering the emissions associated with digital storage in pathology. Here’s a very rough estimate: 📦 70,000 cases/year 🖼️ 8 WSI slides per case (~1 GB each) ⏳ Stored for 20 years Here’s a good primer on data centre emissions and digital…

🥷 GLI1 strikes again! 🧬 Check out this article describing GLI amplification in 85% Low grade OS 🦴 🆕 New fusion partner described 🔬 No morphologic overlap with GLI altered mesenchymal tumours in this study, but may be too soon to tell! Read more to find out…

In machine learning, we make models smarter by ‘messing up’ the training data: random brightness changes, color shifts, rotations, even blur. This trick is called data augmentation. It forces the AI to focus on what really matters, not superficial distractions. #AI #Pathology

Sporadic hypertrophic and nodular port wine stain 🚨 27 cases - Histologic features & IHC profile of this uncommon vascular lesion 🚨 Novel mutation described! Learn more here - bit.ly/446Usej

🚨 Launch Alert! We’re proud to debut a new series evaluating clinical-grade Machine learning tools for cancer diagnosis, starting with prostate adenocarcinoma. Dr. Thaker breaks down diagnosis with the IBEX algorithm: the wins, the flaws, and a granular dive into methods,…

Carcinoma arising in microglandular adenosis (MGACA) is a rare triple-negative breast cancer subtype, often basal-like immune-suppressed (BLIS). Frequent mutations: TP53🧬, BRCA1🔍 & MYC📈.